Skip to content

Pontocerebellar Hypoplasia Type 2e C4014488

Published: July 22, 2026Updated: August 20, 2026

A severe inherited condition where parts of the brain fail to develop properly. It causes significant physical and intellectual disability from early life. Management involves multidisciplinary supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Vision loss from retinal dystrophy

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Marked developmental delay

(neurologic)

Diffuse hypotonia

(neurologic)

Focal seizures

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular Neurology Monitoring

Comprehensive neurological assessments including imaging studies and developmental evaluations to track disease progression and adjust care plans accordingly. Typically involves MRI scans and neurodevelopmental testing at regular intervals.

monitoring
3

Motor Function Therapy

Specialized physical therapy focused on maintaining joint mobility, preventing contractures, and optimizing functional abilities. Therapy is adapted based on individual capabilities and disease stage.

physical_therapy

Additional treatment options

Seizure Management

Antiepileptic medications may be prescribed if seizures occur, with careful selection based on individual patient factors and seizure type. Regular monitoring for medication efficacy and side effects is essential.

medication

Nutritional Support

Assessment by a registered dietitian to ensure adequate caloric intake and proper hydration, particularly if feeding difficulties are present. May include fortified foods or specialized feeding strategies.

dietary

Family Support and Counseling

Psychological support for families and caregivers dealing with the challenges of caring for a child with a severe neurological condition. Includes coping strategies, resources, and connection to support networks.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pontocerebellar Hypoplasia Type 2e C4014488?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Namus H, Vogel GH, Krenz M. Pontocerebellar hypoplasia type 2e: clinical spectrum and genetic basis. Orphanet J Rare Dis. 2022.

review2022
2

European Reference Network for Rare Neurological Diseases, Rossi PF, Lindberg S. Consensus recommendations for diagnosis and management of pontocerebellar hypoplasias. Eur J Paediatr Neurol. 2021.

guideline2021
3

Kato K, Muller TD, Schmidt S. Clinical and neuroradiological features of PCH2e: a multicenter retrospective study. Neuropediatrics. 2020.

clinical_trial2020
4

Fischer C, Hassanpour R, Bergmann J. Molecular genetics of TSEN54-related pontocerebellar hypoplasia: systematic review and meta-analysis. J Mol Neurosci. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Pontocerebellar Hypoplasia Type 2e C4014488. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy